Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
BLFS [NASD]
BioLife Solutions, Inc.
Healthcare | Medical Instruments & Supplies | USA
statements
Index- P/E119.77 EPS (ttm)0.26 Insider Own2.80% Shs Outstand32.97M Perf Week-11.89%
Market Cap1.00B Forward P/E99.36 EPS next Y0.31 Insider Trans-57.32% Shs Float26.50M Perf Month-14.17%
Income2.70M PEG11.98 EPS next Q-0.03 Inst Own78.10% Short Float2.73% Perf Quarter-28.04%
Sales48.10M P/S20.79 EPS this Y214.70% Inst Trans4.52% Short Ratio2.37 Perf Half Y-1.56%
Book/sh6.23 P/B4.96 EPS next Y875.00% ROA1.70% Target Price- Perf Year127.04%
Cash/sh2.79 P/C11.06 EPS next 5Y10.00% ROE1.90% 52W Range13.36 - 47.97 Perf YTD-22.54%
Dividend- P/FCF161.33 EPS past 5Y17.90% ROI-1.10% 52W High-35.58% Beta1.45
Dividend %- Quick Ratio6.60 Sales past 5Y49.50% Gross Margin57.10% 52W Low131.29% ATR2.00
Employees193 Current Ratio7.40 Sales Q/Q77.10% Oper. Margin-11.60% RSI (14)40.91 Volatility10.09% 5.66%
OptionableYes Debt/Eq0.01 EPS Q/Q89.10% Profit Margin5.50% Rel Volume0.94 Prev Close30.90
ShortableYes LT Debt/Eq0.00 EarningsMay 13 AMC Payout0.00% Avg Volume304.22K Price30.90
Recom2.00 SMA20-6.59% SMA50-12.83% SMA200-6.12% Volume0 Change0.00%
Mar-23-21Upgrade The Benchmark Company Hold → Buy $54
Nov-10-20Initiated KeyBanc Capital Markets Overweight $40
Sep-22-20Downgrade Oppenheimer Outperform → Perform
Sep-18-20Initiated Cowen Outperform $33
Aug-11-20Downgrade The Benchmark Company Buy → Hold
Jul-08-20Reiterated Maxim Group Buy $18 → $26
Feb-24-20Initiated Lake Street Buy $25
Feb-19-20Initiated The Benchmark Company Buy $24
Feb-06-20Resumed B. Riley FBR Buy $27
Jan-08-20Initiated Stephens Overweight $23
Nov-21-19Initiated Oppenheimer Outperform $22
Jul-22-19Initiated H.C. Wainwright Buy $23
Nov-10-17Reiterated Maxim Group Buy $7 → $8
Sep-19-17Reiterated Maxim Group Buy $6 → $7
Jul-05-17Upgrade Janney Neutral → Buy $5
Mar-10-17Reiterated Maxim Group Buy $3 → $4
Jan-19-17Initiated Maxim Group Buy $3
May-06-21 04:05PM  
BioLife Solutions to Report First Quarter 2021 Financial Results and Provide Business Update on May 13, 2021
PR Newswire -5.59%
03:00PM  
Earnings Preview: BioLife Solutions, Inc. (BLFS) Q1 Earnings Expected to Decline
Zacks
May-03-21 04:05PM  
BioLife Solutions Announces Closing of Stirling Ultracold Acquisition and Expanded Partnership with Leading Global Biopharma CDMO
PR Newswire
Apr-20-21 08:24PM  
The Recent Pullback in These 3 Stocks Is a Buying Opportunity, Say Analysts
TipRanks
Apr-15-21 08:00AM  
BioLife Solutions Launches New High Capacity Controlled Rate Freezer Line with First Shipment to a Leading Cell Therapy Developer
PR Newswire
Apr-09-21 11:40AM  
HRC or BLFS: Which Is the Better Value Stock Right Now?
Zacks
Apr-06-21 08:00AM  
BioLife Solutions Appoints Two New Independent Board Directors
PR Newswire
Mar-24-21 11:40AM  
HRC vs. BLFS: Which Stock Is the Better Value Option?
Zacks -7.19%
08:59AM  
The Daily Biotech Pulse: Dynavax-Clover Start Phase 2/3 Vaccine Study. BrainStorm Reports Positive MS Readout, NeoGenomics Goes Shopping
Benzinga
Mar-23-21 12:18PM  
5 Top Stock Gainers for Tuesday: Dolphin Entertainment, Benitec
TheStreet.com +8.84%
08:18AM  
The Daily Biotech Pulse: FDA Approvals For Merck, Pacira And Zealand, Roche-Regeneron Ace Late-Stage COVID-19 Study, AlloVir Appoints Gilead Virology Chief As CEO
Benzinga
07:54AM  
Analysts Upgrade BioLife After Stirling Acquisition, Revenue Jump
TheStreet.com
04:45AM  
BioLife Solutions Rises 17% On Stronger-Than-expected FY21 Revenue Outlook
SmarterAnalyst
12:00AM  
Biolife Solutions Inc (BLFS) Q4 2020 Earnings Call Transcript
Motley Fool
Mar-22-21 05:44PM  
BioLife Solutions: Q4 Earnings Insights
Benzinga
05:25PM  
BioLife Solutions, Inc. (BLFS) Reports Q4 Loss, Tops Revenue Estimates
Zacks
05:00PM  
Stirling Ultracold to Merge with BioLife Solutions, the Leader in Gene and Cell Therapy Bioproduction Tools and Services
PR Newswire
04:05PM  
Stirling Ultracold Announces Merger Agreement with BioLife Solutions to Further Support Life-Science Industry with Expertise in Ultra-Low Temperature Storage
PR Newswire
04:05PM  
BioLife Solutions Announces Fourth Quarter and Full Year 2020 Financial Results
PR Newswire
04:03PM  
BioLife Solutions to Acquire Stirling Ultracold in an All-Stock Merger
PR Newswire
02:30PM  
BioLife Solutions, Inc. to Host Earnings Call
ACCESSWIRE
Mar-19-21 10:44AM  
Earnings Preview for BioLife Solutions
Benzinga
Mar-10-21 08:00AM  
BioLife Solutions to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Business Update on March 22, 2021
PR Newswire
Mar-08-21 11:40AM  
HRC vs. BLFS: Which Stock Is the Better Value Option?
Zacks -6.71%
Feb-16-21 08:00AM  
BioLife Solutions Promotes Marcus Schulz to Chief Revenue Officer
PR Newswire
Jan-20-21 12:28PM  
BioLife Solutions (BLFS) Shines Amidst the Pandemic
Insider Monkey
Dec-30-20 08:35AM  
3 Soaring MedTech Stocks That Might Lose Ground in 2021
Zacks
Dec-25-20 07:53AM  
Want to Buy BioLife Solutions (BLFS) Stock? Heres What You Need to Know
Insider Monkey
Dec-22-20 12:07AM  
Estimating The Intrinsic Value Of BioLife Solutions, Inc. (NASDAQ:BLFS)
Simply Wall St.
Dec-14-20 08:42PM  
Is BLFS A Good Stock To Buy Now?
Insider Monkey
Dec-04-20 08:24PM  
BioLife Solutions, Nikola See Activist Action
Barrons.com +6.43%
Dec-01-20 08:00AM  
iVexSol Announces Series A Funding
GlobeNewswire
08:00AM  
BioLife Solutions & Casdin Capital Innovation Accelerator Announce New Investments in Cell & Gene Therapy Bioproduction Tools
PR Newswire
Nov-19-20 08:00AM  
BioLife Solutions Ranked 403rd Fastest Growing Company in North America on Deloitte's 2020 Technology Fast 500
PR Newswire
Nov-06-20 03:30PM  
Biolife Solutions Inc (BLFS) Q3 2020 Earnings Call Transcript
Motley Fool +7.77%
Nov-05-20 04:05PM  
BioLife Solutions Announces Third Quarter 2020 Financial Results
PR Newswire
02:30PM  
BioLife Solutions, Inc. to Host Earnings Call
ACCESSWIRE
Oct-29-20 04:05PM  
BioLife Solutions to Report Third Quarter 2020 Financial Results and Provide Business Update on November 5, 2020
PR Newswire +5.64%
Oct-23-20 07:20AM  
Here's What BioLife Solutions, Inc.'s (NASDAQ:BLFS) Shareholder Ownership Structure Looks Like
Simply Wall St.
Oct-22-20 04:06PM  
Shopify Too Pricey? This Is Why $1,000 Stocks Shouldn't Scare You
Investor's Business Daily
Oct-14-20 08:00AM  
BioLife Solutions SciSafe Division Secures $2.7 Million Cold Chain and Storage Contract for COVID-19 Vaccines
PR Newswire
Oct-01-20 08:00AM  
BioLife Solutions Closes Acquisition of SciSafe, a High-Growth Biostorage Service Provider to the Cell and Gene Therapy Industry
PR Newswire
Sep-21-20 02:26PM  
BioLife Solutions to Buy SciSafe in $30 Million Deal
Motley Fool
08:00AM  
BioLife Solutions to Acquire SciSafe, a High-Growth Biostorage Service Provider to the Cell and Gene Therapy Industry
PR Newswire
Sep-08-20 07:45AM  
Do Its Financials Have Any Role To Play In Driving BioLife Solutions, Inc.'s (NASDAQ:BLFS) Stock Up Recently?
Simply Wall St.
Aug-25-20 05:53PM  
BioLife Solutions Named one of the Top 100 Companies in Washington State
PR Newswire
Aug-06-20 04:05PM  
BioLife Solutions Announces Second Quarter 2020 Financial Results
PR Newswire
Aug-05-20 08:38AM  
Should You Buy BioLife (BLFS) Ahead of Earnings?
Zacks
Aug-03-20 09:33AM  
When Should You Buy BioLife Solutions, Inc. (NASDAQ:BLFS)?
Simply Wall St. +8.69%
Jul-30-20 05:45PM  
BioLife Solutions to Report Second Quarter 2020 Financial Results and Provide Business Update on August 6, 2020
PR Newswire
Jul-15-20 08:00AM  
BioLife Solutions evo® Cold Chain Management Platform Now Supporting Over 100 Early Stage Cell & Gene Therapy Clinical Trials
PR Newswire
Jul-07-20 12:45PM  
BioLife Solutions Announces Closing of $86 Million Public Offering of Common Stock
PR Newswire
Jul-06-20 09:08AM  
Moving Average Crossover Alert: BioLife Solutions
Zacks
06:57AM  
BioLife (BLFS) Catches Eye: Stock Jumps 12.1%
Zacks
Jul-02-20 02:48PM  
Here's Why BioLife Solutions Jumped Higher Today
Motley Fool +12.09%
07:40AM  
BioLife Solutions Announces Pricing of $75 Million Public Offering of Common Stock
PR Newswire
12:40AM  
Edited Transcript of BLFS.OQ earnings conference call or presentation 14-May-20 8:30pm GMT
Thomson Reuters StreetEvents
Jul-01-20 04:02PM  
BioLife Solutions Announces $9.6 Million to $9.8 Million in Preliminary Revenue for Q2 2020
PR Newswire
04:01PM  
BioLife Solutions Announces Proposed Public Offering of Common Stock
PR Newswire
Jun-26-20 11:45AM  
Is BioLife Solutions, Inc. (BLFS) A Good Stock To Buy?
Insider Monkey
May-18-20 04:15PM  
BioLife Solutions Promotes Marcus Schulz to Vice President, Global Sales
PR Newswire
May-14-20 08:30PM  
Biolife Solutions Inc (BLFS) Q1 2020 Earnings Call Transcript
Motley Fool
04:05PM  
BioLife Solutions Announces First Quarter 2020 Financial Results
PR Newswire
May-13-20 12:52PM  
CytoDyn (CYDY) to Report Q4 Earnings: What's in the Cards?
Zacks
10:20AM  
Why Earnings Season Could Be Great for BioLife Solutions (BLFS)
Zacks
May-11-20 08:00AM  
BioLife Solutions to Report First Quarter 2020 Financial Results and Provide Business Update on May 14th, 2020
PR Newswire +9.40%
May-01-20 08:00AM  
BioLife Solutions Announces Preliminary First Quarter 2020 Revenue
PR Newswire
Apr-20-20 06:44AM  
Is BioLife Solutions, Inc. (NASDAQ:BLFS) A Volatile Stock?
Simply Wall St.
Mar-30-20 06:35PM  
Edited Transcript of BLFS earnings conference call or presentation 11-Mar-20 8:30pm GMT
Thomson Reuters StreetEvents
Mar-28-20 08:45AM  
How Does BioLife Solutions's (NASDAQ:BLFS) P/E Compare To Its Industry, After The Share Price Drop?
Simply Wall St.
Mar-14-20 08:58AM  
Did You Miss BioLife Solutions's (NASDAQ:BLFS) Whopping 428% Share Price Gain?
Simply Wall St.
08:38AM  
How Does BioLife Solutions's (NASDAQ:BLFS) P/E Compare To Its Industry, After The Share Price Drop?
Simply Wall St.
Mar-11-20 04:29PM  
BioLife Solutions Announces Fourth Quarter and Full Year 2019 Financial Results
PR Newswire -7.20%
02:30PM  
BioLife Solutions, Inc. to Host Earnings Call
ACCESSWIRE
Feb-17-20 06:14AM  
What Does BioLife Solutions, Inc.'s (NASDAQ:BLFS) Share Price Indicate?
Simply Wall St.
Feb-12-20 08:00AM  
BioLife Solutions Announces Earnings Call Date and Upcoming Investor and Scientific Conferences
PR Newswire
Feb-07-20 07:46AM  
Analysts Back a Turnaround at BioLife Solutions
Investopedia
Jan-22-20 05:46AM  
Here's Why We Think BioLife Solutions (NASDAQ:BLFS) Is Well Worth Watching
Simply Wall St.
Jan-04-20 07:25AM  
Edited Transcript of BLFS earnings conference call or presentation 12-Nov-19 9:30pm GMT
Thomson Reuters StreetEvents
Dec-30-19 11:35AM  
How Much Did BioLife Solutions, Inc.'s (NASDAQ:BLFS) CEO Pocket Last Year?
Simply Wall St.
Dec-26-19 08:13PM  
What could you have made by investing $1,000 in these Washington companies a decade ago?
American City Business Journals
Dec-19-19 09:26PM  
Smart Money Dumping BioLife Solutions, Inc. (BLFS)
Insider Monkey
Dec-04-19 06:58AM  
Can BioLife Solutions, Inc. (NASDAQ:BLFS) Maintain Its Strong Returns?
Simply Wall St.
Dec-02-19 08:00AM  
BioLife Solutions Announces Executive Appointments to Support Integration of Acquired Companies
PR Newswire -5.85%
Nov-22-19 03:01AM  
Seattle has potential as a biotech hub, but more companies must stay here and grow
American City Business Journals
Nov-12-19 04:03PM  
BioLife Solutions Acquires Custom Biogenic Systems
PR Newswire
04:01PM  
BioLife Solutions Announces Third Quarter 2019 Financial Results
PR Newswire
Nov-11-19 08:07AM  
Is BioLife Solutions, Inc. (NASDAQ:BLFS) Creating Value For Shareholders?
Simply Wall St.
Nov-07-19 06:15PM  
BioLife Solutions, Inc. (BLFS): Hedge Fund Interest Cooling Off
Insider Monkey
08:00AM  
BioLife Solutions Named one of the Fastest Growing Companies in North America on Deloitte's 2019 Technology Fast 500
PR Newswire
Oct-31-19 08:23PM  
BioLife Solutions to Report Third Quarter 2019 Financial Results and Provide Business Update on November 12, 2019
PR Newswire
Oct-22-19 09:13AM  
Medical Products Industry Outlook: Prospects Seem Promising
Zacks
Oct-14-19 09:41AM  
A Quick Look at 2 Positive Looking Biotech Plays
TheStreet.com +6.44%
08:00AM  
BioLife Solutions Awarded Three New Patents for Cryopreservation, Thawing and Cold Chain Transport Technologies
PR Newswire
Sep-24-19 08:00AM  
iVexSol Announces $2M in Seed Funding
GlobeNewswire -11.29%
08:00AM  
BioLife Solutions Announces Cell and Gene Therapy Bioproduction Innovation Accelerator
PR Newswire
Sep-16-19 08:00AM  
BioLife Solutions Announces New evo® Cold Chain Customers
PR Newswire
Sep-11-19 10:15PM  
Biolife Solutions Inc (BLFS) President & CEO Michael Rice Sold $553,992 of Shares
GuruFocus.com
Sep-06-19 10:15PM  
Biolife Solutions Inc (BLFS) CFO Greef Roderick De Sold $593,400 of Shares
GuruFocus.com
Sep-03-19 12:30PM  
Edited Transcript of BLFS earnings conference call or presentation 8-Aug-19 8:30pm GMT
Thomson Reuters StreetEvents
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; and the ThawSTAR line that includes automated vial and cryobag thawing products that control the heat and timing of the thawing process of biologic materials. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage services. The company markets and sells its products directly, as well as through third party distributors. BioLife Solutions, Inc. was founded in 1987 and is headquartered in Bothell, Washington.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Rice MichaelCEOMay 06Option Exercise1.6411,46118,796282,475May 06 08:00 PM
Rice MichaelCEOMay 06Sale30.4111,461348,529271,014May 06 08:00 PM
Rice MichaelCEOMay 04Option Exercise1.6411,46118,796282,475May 06 08:00 PM
Rice MichaelCEOMay 04Sale30.1511,461345,549271,014May 06 08:00 PM
Mathew Aby J.Exec VP & Chief Scientific OffApr 21Option Exercise1.6410,00016,400220,679Apr 21 08:02 PM
Mathew Aby J.Exec VP & Chief Scientific OffApr 21Sale32.2610,000322,600210,679Apr 21 08:02 PM
Schulz MarcusChief Revenue OfficerApr 20Sale32.1065020,86539,145Apr 21 08:01 PM
Foster Karen A.Chief Quality OfficerApr 19Option Exercise1.6416,33226,78489,980Apr 21 08:01 PM
Mathew Aby J.Exec VP & Chief Scientific OffApr 19Option Exercise1.6410,00016,400220,679Apr 21 08:02 PM
Foster Karen A.Chief Quality OfficerApr 19Sale32.5816,332532,09773,648Apr 21 08:01 PM
Mathew Aby J.Exec VP & Chief Scientific OffApr 19Sale32.6210,000326,200210,679Apr 21 08:02 PM
Berard ToddChief Marketing OfficerApr 16Option Exercise1.646,16010,10285,726Apr 19 08:55 PM
Berard ToddChief Marketing OfficerApr 16Sale33.386,160205,62179,566Apr 19 08:55 PM
Berard ToddChief Marketing OfficerApr 15Option Exercise1.646,16010,10285,726Apr 19 08:55 PM
DE GREEF RODERICKCFO & COOApr 15Sale33.695,000168,450175,538Apr 15 09:43 PM
Berard ToddChief Marketing OfficerApr 15Sale33.766,160207,96279,566Apr 19 08:55 PM
Hinson Andrew GDirectorApr 15Sale33.802,50084,50011,961Apr 19 08:54 PM
DE GREEF RODERICKCFO & COOApr 14Sale33.835,000169,150180,538Apr 15 09:43 PM
DE GREEF RODERICKCFO & COOApr 13Option Exercise1.7010,91918,587191,497Apr 15 09:43 PM
DE GREEF RODERICKCFO & COOApr 13Sale35.0810,919383,039185,538Apr 15 09:43 PM
Rice MichaelPresident & CEOApr 08Option Exercise1.6411,46118,796273,988Apr 12 09:31 PM
Schulz MarcusChief Revenue OfficerApr 08Sale35.772248,01239,795Apr 12 09:31 PM
Rice MichaelPresident & CEOApr 08Sale35.3211,461404,803262,527Apr 12 09:31 PM
Berard ToddChief Marketing OfficerApr 01Sale36.532,825103,19777,204Apr 05 09:31 PM
DE GREEF RODERICKCFO & COOApr 01Sale36.533,855140,823182,316Apr 05 09:31 PM
Rice MichaelPresident & CEOApr 01Sale36.5310,149370,743262,527Apr 05 09:31 PM
Foster Karen A.Chief Quality OfficerApr 01Sale36.533,414124,71370,794Apr 05 09:32 PM
Mathew Aby J.Exec VP & Chief Scientific OffApr 01Sale36.534,020146,851200,981Apr 05 09:32 PM
DE GREEF RODERICKCFO & COOMar 26Sale35.012,893101,284176,239Mar 30 08:01 PM
Berard ToddChief Marketing OfficerMar 26Sale35.012,12074,22172,750Mar 30 08:00 PM
Mathew Aby J.Exec VP & Chief Scientific OffMar 26Sale35.013,016105,590200,981Mar 30 08:02 PM
Foster Karen A.Chief Quality OfficerMar 26Sale35.012,56289,69665,411Mar 30 08:01 PM
Rice MichaelPresident & CEOMar 26Sale35.013,809133,353246,522Mar 30 08:01 PM
DE GREEF RODERICKCFO & COOMar 25Option Exercise1.8110,00018,100189,132Mar 25 08:03 PM
DE GREEF RODERICKCFO & COOMar 25Sale37.7110,000377,100179,132Mar 25 08:03 PM
Mathew Aby J.Exec VP & Chief Scientific OffMar 24Option Exercise1.6410,00016,400213,997Mar 24 09:33 PM
DE GREEF RODERICKCFO & COOMar 24Option Exercise1.8110,00018,100189,132Mar 25 08:03 PM
Mathew Aby J.Exec VP & Chief Scientific OffMar 24Sale40.1810,000401,800203,997Mar 24 09:33 PM
DE GREEF RODERICKCFO & COOMar 24Sale40.1810,000401,800179,132Mar 25 08:03 PM
DE GREEF RODERICKCFO & COOMar 23Option Exercise1.8110,00018,100189,132Mar 25 08:03 PM
DE GREEF RODERICKCFO & COOMar 23Sale41.8310,000418,300179,132Mar 25 08:03 PM
Foster Karen A.Chief Quality OfficerMar 22Option Exercise1.6416,33226,78484,305Mar 24 09:33 PM
Mathew Aby J.Exec VP & Chief Scientific OffMar 22Option Exercise1.6410,00016,400213,997Mar 24 09:33 PM
Foster Karen A.Chief Quality OfficerMar 22Sale37.5616,332613,43067,973Mar 24 09:33 PM
Mathew Aby J.Exec VP & Chief Scientific OffMar 22Sale37.8010,000378,000203,997Mar 24 09:33 PM
Berard ToddChief Marketing OfficerMar 16Option Exercise1.646,16010,10281,030Mar 17 08:01 PM
Berard ToddChief Marketing OfficerMar 16Sale36.726,160226,19574,870Mar 17 08:01 PM
Berard ToddChief Marketing OfficerMar 15Option Exercise1.646,16010,10281,030Mar 17 08:01 PM
Berard ToddChief Marketing OfficerMar 15Sale36.916,160227,36674,870Mar 17 08:01 PM
Hinson Andrew GDirectorMar 15Sale37.322,50093,30014,461Mar 17 08:01 PM
Foster Karen A.Chief Quality OfficerFeb 26Sale39.5728411,23867,973Mar 02 08:42 PM
Mathew Aby J.Exec VP & Chief Scientific OffFeb 26Sale39.5740315,947203,997Mar 02 08:42 PM
Rice MichaelPresident & CEOFeb 26Sale39.5786134,070250,331Mar 02 08:43 PM
Foster Karen A.Chief Quality OfficerFeb 22Option Exercise1.6416,33426,78884,591Feb 24 08:00 PM
Foster Karen A.Chief Quality OfficerFeb 22Sale39.6616,334647,80668,257Feb 24 08:00 PM
DE GREEF RODERICKCFO & COOFeb 19Sale40.764,509183,787179,132Feb 19 08:00 PM
Mathew Aby J.Exec VP & Chief Scientific OffFeb 19Sale40.764,728192,713204,400Feb 19 08:01 PM
Rice MichaelPresident & CEOFeb 19Sale40.7610,107411,961251,192Feb 19 08:00 PM
Berard ToddChief Marketing OfficerFeb 19Sale40.761,87676,46674,870Feb 19 08:00 PM
Foster Karen A.Chief Quality OfficerFeb 19Sale40.763,344136,30168,257Feb 19 08:02 PM
DE GREEF RODERICKCFO & COOFeb 18Sale40.674,520183,828183,641Feb 19 08:00 PM
Mathew Aby J.Exec VP & Chief Scientific OffFeb 18Sale40.674,741192,816209,128Feb 19 08:01 PM
Rice MichaelPresident & CEOFeb 18Sale40.6710,132412,068261,299Feb 19 08:00 PM
Berard ToddChief Marketing OfficerFeb 18Sale40.671,88276,54176,746Feb 19 08:00 PM
Foster Karen A.Chief Quality OfficerFeb 18Sale40.673,353136,36771,601Feb 19 08:02 PM
DE GREEF RODERICKCFO & COOFeb 17Sale41.554,424183,817188,161Feb 19 08:00 PM
Mathew Aby J.Exec VP & Chief Scientific OffFeb 17Sale41.554,640192,792213,869Feb 19 08:01 PM
Rice MichaelPresident & CEOFeb 17Sale41.559,917412,051271,431Feb 19 08:00 PM
Berard ToddChief Marketing OfficerFeb 17Sale41.551,84276,53578,628Feb 19 08:00 PM
Foster Karen A.Chief Quality OfficerFeb 17Sale41.553,281136,32674,954Feb 19 08:02 PM
Berard ToddChief Marketing OfficerFeb 16Option Exercise1.6412,32420,21170,042Feb 18 09:04 PM
Berard ToddChief Marketing OfficerFeb 16Sale44.4812,324548,11163,878Feb 18 09:04 PM
Hinson Andrew GDirectorFeb 16Sale45.672,500114,17516,961Feb 17 08:00 PM
VILLIGER WALTER10% OwnerFeb 05Sale40.9040,0001,636,0003,281,778Feb 08 09:14 PM
Mathew Aby J.Exec VP & Chief Scientific OffFeb 04Option Exercise1.1218,48320,719198,905Feb 08 09:14 PM
Mathew Aby J.Exec VP & Chief Scientific OffFeb 04Sale40.0218,483739,690180,422Feb 08 09:14 PM
VILLIGER WALTER10% OwnerFeb 04Sale40.658,538347,0703,321,778Feb 08 09:14 PM
Mathew Aby J.Exec VP & Chief Scientific OffFeb 02Option Exercise1.1218,48420,721198,906Feb 03 08:01 PM
Mathew Aby J.Exec VP & Chief Scientific OffFeb 02Sale40.2318,484743,611180,422Feb 03 08:01 PM
Mathew Aby J.Exec VP & Chief Scientific OffFeb 01Option Exercise1.1218,48420,721198,906Feb 03 08:01 PM
Mathew Aby J.Exec VP & Chief Scientific OffFeb 01Sale38.7118,484715,516180,422Feb 03 08:01 PM
VILLIGER WALTER10% OwnerJan 25Sale41.5850,0002,079,0003,330,316Jan 26 08:00 PM
VILLIGER WALTER10% OwnerJan 22Sale42.4829,8111,266,3713,380,316Jan 26 08:00 PM
VILLIGER WALTER10% OwnerJan 20Sale41.0329,1821,197,3373,410,127Jan 21 08:03 PM
VILLIGER WALTER10% OwnerJan 19Sale40.3040,0001,612,0003,439,309Jan 21 08:03 PM
VILLIGER WALTER10% OwnerJan 15Sale40.6229,3381,191,7103,479,309Jan 19 08:00 PM
VILLIGER WALTER10% OwnerJan 14Sale43.0822,152954,3083,508,647Jan 19 08:00 PM
VILLIGER WALTER10% OwnerJan 12Sale40.408,435340,7743,530,799Jan 13 08:02 PM
Schulz MarcusChief Revenue OfficerJan 12Sale41.012,00082,02037,107Feb 16 08:01 PM
VILLIGER WALTER10% OwnerJan 11Sale40.2480,0003,219,2013,539,234Jan 13 08:02 PM
Schulz MarcusVice President, Global SalesJan 08Sale39.0129311,43039,107Jan 13 08:02 PM
VILLIGER WALTER10% OwnerJan 07Sale39.5530,0001,186,5003,619,234Jan 08 08:01 PM
VILLIGER WALTER10% OwnerJan 06Sale41.5315,075626,0653,649,234Jan 08 08:01 PM
VILLIGER WALTER10% OwnerJan 05Sale42.5418,948806,0483,664,309Jan 08 08:01 PM
Rice MichaelPresident & CEODec 01Sale35.4981328,853202,843Dec 03 08:30 PM
Mathew Aby J.Exec VP & Chief Scientific OffDec 01Sale35.4938013,486180,422Dec 03 08:31 PM
Foster Karen A.Chief Quality OfficerDec 01Sale35.491665,89150,742Dec 03 08:31 PM
Casdin Partners Master Fund, L10% OwnerNov 24Buy22.501,600,00036,000,0007,440,107Nov 27 05:23 PM
GIRSCHWEILER THOMASDirectorNov 24Sale22.501,600,00036,000,00047,774Nov 30 07:49 PM
VILLIGER WALTER10% OwnerNov 19Sale33.3536,8481,228,8813,683,257Nov 20 08:31 PM
open in yahoo | open in reuters | open in marketwatch | open in google
affiliate • advertise • contact • privacy • help
Do not sell my personal information
Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2021 FINVIZ.com. All Rights Reserved.